Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
Wang B, Liu Y, Hou G, Wang L, Lv N, Xu Y, Xu Y, Wang X, Xuan Z, Jing Y, Li H, Jin X, Deng A, Wang L, Gao X, Dou L, Liang J, Chen C, Li Y, Yu L.
Wang B, et al. Among authors: lv n.
Oncotarget. 2016 May 31;7(22):32065-78. doi: 10.18632/oncotarget.7028.
Oncotarget. 2016.
PMID: 27062340
Free PMC article.